An analytical method is a way of answering a specified question about a sample. Before reading its headline number, identify that question: molecular identity, amount, related impurities or change over time. The same instrument can support different methods, and a technical-looking output does not show that a method was suitable for the reported conclusion. A useful review connects the intended use with the method’s performance, controls and data processing.

Start with the method’s purpose

Separate identity, quantity, purity, potency, and stability. These are related but not interchangeable attributes. A method designed to estimate relative chromatographic purity may not establish absolute content. A mass-to-charge signal may support an identity assignment but does not, by itself, quantify all impurities. Ask whether the report describes the analyte, sample matrix, reference standard, detector, sample preparation, and acceptance criteria.

Check validation in the intended range

Validation asks whether the procedure performs adequately for its defined purpose. Relevant characteristics can include specificity, accuracy, precision, range, linearity, detection or quantitation limits, and robustness. Which characteristics matter depends on whether the test is qualitative or quantitative and on the decision the result supports. The FDA’s guidance on analytical procedures and method validation describes validation evidence used to support identity, strength, quality, purity, and potency assessments for drug substances and products.

Read the controls and data handling

Look for blanks, positive or reference controls, replicate measurements, calibration information, and system suitability checks. Review how peaks or signals were integrated, how excluded data were handled, and whether raw data or representative traces are available. Sample preparation can introduce losses, carryover, degradation, or matrix effects. A single attractive trace is less informative than a documented method with appropriate controls and repeatability.

Translate the intended use into a measurement requirement

Suppose the question is whether a small impurity can be distinguished from a large main peak. The relevant performance involves separation, detection and reliable integration in that setting. If the question is the amount of peptide in the sample, calibration and the basis of the reported amount become central. A method can be useful for the first task while being insufficient for the second.

This is why validation characteristics should be selected for the intended use rather than collected as a generic badge. An identification procedure, an assay and a trace-impurity procedure do not need exactly the same demonstration. The ICH Q2(R2) and FDA method-validation documents are frameworks for thinking about those requirements; they are not certificates for an unspecified research sample.

Accuracy, precision and selectivity are different checks

Precision concerns agreement among repeated measurements under stated conditions. Accuracy concerns agreement with an accepted reference or value under an appropriate assessment. Selectivity concerns the ability to distinguish the intended measurement from relevant interference. Repeating the same biased result can look precise while remaining inaccurate. A clean-looking peak can still contain an unresolved component.

The range matters as well. Evidence that a procedure performs adequately at one concentration does not establish its performance far below that range or in a different sample matrix. Look for the conditions under which performance was demonstrated and the conditions under which the reported sample was actually measured.

Read one analytical result backward through its controls

Start with the reported value and locate the calculation that produced it. For a calibrated assay, identify the reference material, calibration model and units. For a chromatographic area percentage, identify which peaks entered the denominator and which were excluded. Then connect the processed output to the raw acquisition and the sample identifier. A missing link should remain a missing link.

Blank samples, system-suitability results and reference materials can reveal different problems. A blank can help identify background or carryover. A suitability check asks whether the analytical system met stated conditions for that run. A reference material helps anchor a comparison. None of these alone proves that every relevant sample attribute was measured.

Data handling needs the same attention as the instrument. Changing a baseline, removing an injection or reintegrating a shoulder can alter the final number. The record should preserve the original data and explain the change. A later reviewer needs to understand why the final result differs, not merely see that a new PDF replaced the old one.

What to request when the report is too short

Ask for the method identifier and version, the sample link, the relevant trace or spectrum and the calculation basis. The request should follow the claim rather than demand every conceivable test. For research peptides assessed online through a short COA, these attachments can clarify whether a number concerns identity, detected signal or a calibrated quantity.

The next step is then specific: resolve the missing evidence required for that one conclusion. If the issuer cannot explain the percentage’s basis, describe it as an ambiguous reported percentage. Do not promote the ambiguity into an exact amount or a general quality verdict. The purity-versus-content article works through that distinction in more detail.

What a method report cannot prove

A method report applies to the tested sample and conditions. It cannot authenticate a different lot, establish biological activity without a relevant assay, or prove clinical outcomes. Confidence is lower when key parameters, reference standards, acceptance criteria, or uncertainty are missing.

  • Write down the question before evaluating the result.
  • Match the method’s scope to the property claimed.
  • Check validation, controls, sample identity, and data transparency.
  • Describe conclusions within the report’s stated limitations.

How to interpret the next research step

A certificate of analysis should be read as a report about a specified lot and a specified method. Its scope depends on the laboratory, sample chain, reference standard, acceptance criteria, and date of testing. Missing method details do not prove that a result is wrong, but they make independent interpretation harder. State what the document actually verifies.

Continue with the peptide research literacy primer or the guide to traceable records.

How to read an analytical method: intended use and validation

Method performance is not a universal property. Selectivity, accuracy, precision, detection or quantitation limits, and reportable range matter according to the analytical question. A method fit for confirming one identity may not be fit for quantifying a low-level impurity. Compare the stated purpose with the performance evidence using ICH Q2(R2) and the lifecycle perspective in ICH Q14. For concrete examples, read the COA guide, HPLC purity versus content, and peptide identity by mass spectrometry.

Questions that expose overinterpretation

Ask whether the result is qualitative or quantitative, which reference standard was used, whether a suitable blank and controls were run, and how measurement uncertainty was handled. A chromatogram without its method, peak assignment, and integration rules cannot support a robust purity comparison. Likewise, a mass match alone may not resolve positional isomers or all sequence ambiguities. The result should be reported within the scope that was actually validated.

A reported purity value

Suppose a report provides a chromatogram and says the main peak accounts for a large share of integrated area. Before interpreting it, record the detector mode, which peaks were counted, whether co-elution was assessed, and how the sample was prepared. Then ask whether the report also contains an assay for the amount of target substance. If it does not, avoid describing the chromatographic percentage as content. If the main peak has no independent identity evidence, avoid calling it a confirmed sequence. This disciplined wording preserves the useful observation while leaving open the questions the method did not address.